[
    {
        "id": "4713256",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-08-10T09:04:02-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4713256-nektar-therapeutics-nktr-q2-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4691694",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-05-09T22:40:25-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics, Inc. (NKTR) Q1 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4691694-nektar-therapeutics-inc-nktr-q1-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4675850",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-04T22:54:09-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Q4 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4675850-nektar-therapeutics-nktr-q4-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4648864",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-07T21:11:10-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Q3 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4648864-nektar-therapeutics-nktr-q3-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4625756",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-08-08T22:58:10-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Q2 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4625756-nektar-therapeutics-nktr-q2-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4602299",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-09T22:14:06-04:00",
            "isLockedPro": false,
            "commentCount": 5,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4602299-nektar-therapeutics-nktr-ceo-howard-robin-on-q3-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4552990",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-03T23:15:27-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Q3 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4552990-nektar-therapeutics-nktr-q3-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4491498",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-02-28T20:07:11-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4491498-nektar-therapeutics-nktr-ceo-howard-robin-on-q4-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4465824",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-11-04T23:47:01-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4465824-nektar-therapeutics-nktr-ceo-howard-robin-on-q3-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4445739",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-08-05T22:00:47-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q2 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4445739-nektar-therapeutics-nktr-ceo-howard-robin-on-q2-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4425603",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-05-07T12:48:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q1 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4425603-nektar-therapeutics-nktr-ceo-howard-robin-on-q1-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4409315",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-02-26T03:01:04-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4409315-nektar-therapeutics-nktr-ceo-howard-robin-on-q4-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "4400021",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-01-20T18:08:36-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At 39th Annual J.P. Morgan Healthcare Conference",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4400021-nektar-therapeutics-nktr-presents-39th-annual-j-p-morgan-healthcare-conference"
        }
    },
    {
        "id": "4385657",
        "type": "transcript",
        "attributes": {
            "publishOn": "2020-11-05T23:57:05-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4385657-nektar-therapeutics-nktr-ceo-howard-robin-on-q3-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "4365710",
        "type": "transcript",
        "attributes": {
            "publishOn": "2020-08-07T10:20:52-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q2 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4365710-nektar-therapeutics-nktr-ceo-howard-robin-on-q2-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "4344519",
        "type": "transcript",
        "attributes": {
            "publishOn": "2020-05-08T03:31:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q1 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4344519-nektar-therapeutics-nktr-ceo-howard-robin-on-q1-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "4328451",
        "type": "transcript",
        "attributes": {
            "publishOn": "2020-02-28T22:06:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q4 2019 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4328451-nektar-therapeutics-nktr-ceo-howard-robin-on-q4-2019-results-earnings-call-transcript"
        }
    },
    {
        "id": "4316826",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2020-01-14T14:50:45-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4316826-nektar-therapeutics-nktr-presents-38th-annual-j-p-morgan-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4308311",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2019-11-21T12:14:10-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At Jefferies Global Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4308311-nektar-therapeutics-nktr-presents-jefferies-global-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4305474",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2019-11-11T13:33:05-05:00",
            "isLockedPro": false,
            "commentCount": 5,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At 34th Annual Meeting of SITC -",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4305474-nektar-therapeutics-nktr-presents-34th-annual-meeting-of-sitc"
        }
    },
    {
        "id": "4303473",
        "type": "transcript",
        "attributes": {
            "publishOn": "2019-11-06T21:52:08-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2019 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4303473-nektar-therapeutics-nktr-ceo-howard-robin-on-q3-2019-results-earnings-call-transcript"
        }
    },
    {
        "id": "4283654",
        "type": "transcript",
        "attributes": {
            "publishOn": "2019-08-08T23:30:41-04:00",
            "isLockedPro": false,
            "commentCount": 2,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q2 2019 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4283654-nektar-therapeutics-nktr-ceo-howard-robin-on-q2-2019-results-earnings-call-transcript"
        }
    },
    {
        "id": "4270378",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2019-06-14T16:04:12-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At EULAR 2019 - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4270378-nektar-therapeutics-nktr-presents-eular-2019-slideshow"
        }
    },
    {
        "id": "4261818",
        "type": "transcript",
        "attributes": {
            "publishOn": "2019-05-09T00:31:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q1 2019 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4261818-nektar-therapeutics-nktr-ceo-howard-robin-on-q1-2019-results-earnings-call-transcript"
        }
    },
    {
        "id": "4245525",
        "type": "transcript",
        "attributes": {
            "publishOn": "2019-02-28T22:57:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2018 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4245525-nektar-therapeutics-nktr-ceo-howard-robin-on-q4-2018-results-earnings-call-transcript"
        }
    },
    {
        "id": "4232539",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2019-01-10T05:59:42-05:00",
            "isLockedPro": false,
            "commentCount": 8,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4232539-nektar-therapeutics-nktr-presents-37th-annual-j-p-morgan-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4219680",
        "type": "transcript",
        "attributes": {
            "publishOn": "2018-11-07T23:44:19-05:00",
            "isLockedPro": false,
            "commentCount": 16,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) CEO Howard Robin on Q3 2018 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4219680-nektar-therapeutics-nktr-ceo-howard-robin-on-q3-2018-results-earnings-call-transcript"
        }
    },
    {
        "id": "4196863",
        "type": "transcript",
        "attributes": {
            "publishOn": "2018-08-08T23:46:03-04:00",
            "isLockedPro": false,
            "commentCount": 5,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin On Q2 2018 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4196863-nektar-therapeutics-nktr-ceo-howard-robin-on-q2-2018-results-earnings-call-transcript"
        }
    },
    {
        "id": "4172730",
        "type": "transcript",
        "attributes": {
            "publishOn": "2018-05-11T00:27:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar's (NKTR) CEO Howard Robin on Q1 2018 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4172730-nektars-nktr-ceo-howard-robin-on-q1-2018-results-earnings-call-transcript"
        }
    },
    {
        "id": "4156727",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2018-03-15T13:18:25-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4156727-nektar-therapeutics-nktr-presents-38th-annual-cowen-and-company-healthcare-conference"
        }
    },
    {
        "id": "4152660",
        "type": "transcript",
        "attributes": {
            "publishOn": "2018-03-01T23:40:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q4 2017 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4152660-nektar-therapeutics-nktr-ceo-howard-robin-on-q4-2017-results-earnings-call-transcript"
        }
    },
    {
        "id": "4147334",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2018-02-15T15:18:04-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Bristol-Myers Squibb (BMY) and Nektar Therapeutics (NKTR) agree to at develop and commercialize the combinations of NKTR-214 and Opdivo (nivolumab) an",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4147334-bristol-myers-squibb-bmy-and-nektar-therapeutics-nktr-agree-to-develop-and-commercialize"
        }
    },
    {
        "id": "4136638",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2018-01-10T13:26:58-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4136638-nektar-therapeutics-nktr-presents-36th-annual-j-p-morgan-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4128518",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2017-11-29T14:16:19-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At PiperJaffray 29th Annual Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4128518-nektar-therapeutics-nktr-presents-piperjaffray-29th-annual-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4125552",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2017-11-16T13:43:18-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At Jefferies 2017 London Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4125552-nektar-therapeutics-nktr-presents-jefferies-2017-london-healthcare-conference-slideshow"
        }
    },
    {
        "id": "4124301",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2017-11-13T12:51:33-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At Society For Immunotherapy Of Cancer - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4124301-nektar-therapeutics-nktr-presents-society-for-immunotherapy-of-cancer-slideshow"
        }
    },
    {
        "id": "4122039",
        "type": "transcript",
        "attributes": {
            "publishOn": "2017-11-07T22:08:32-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q3 2017 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4122039-nektar-therapeutics-nktr-ceo-howard-robin-on-q3-2017-results-earnings-call-transcript"
        }
    },
    {
        "id": "4096619",
        "type": "transcript",
        "attributes": {
            "publishOn": "2017-08-08T22:01:09-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' (NKTR) CEO Howard Robin on Q2 2017 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4096619-nektar-therapeutics-nktr-ceo-howard-robin-on-q2-2017-results-earnings-call-transcript"
        }
    },
    {
        "id": "4088493",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2017-07-18T14:38:32-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Updates On Topline Results of Oral Human Abuse Potential (NKTR-181) - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4088493-nektar-therapeutics-nktr-updates-on-topline-results-of-oral-human-abuse-potential-nktrminus"
        }
    },
    {
        "id": "4079645",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2017-06-07T14:45:11-04:00",
            "isLockedPro": false,
            "commentCount": 3,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics (NKTR) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4079645-nektar-therapeutics-nktr-presents-jefferies-2017-global-healthcare-conference-slideshow"
        }
    },
    {
        "id": "1820942",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-11-07T21:54:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1820942-nektar-therapeutics-ceo-discusses-q3-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1735362",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-10-08T18:35:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Hosts Investor and Analyst R&D Day Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1735362-nektar-therapeutics-ceo-hosts-investor-and-analyst-r-and-d-day-conference-transcript"
        }
    },
    {
        "id": "1717462",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-09-27T12:45:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Discusses Preliminary Topline Results from Phase 2 Efficacy Study for NKTR-181 Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1717462-nektar-therapeutics-ceo-discusses-preliminary-topline-results-from-phase-2-efficacy-study-for-nktrminus-181-conference-transcript"
        }
    },
    {
        "id": "1621772",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-08-08T21:45:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Discusses Q2 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1621772-nektar-therapeutics-ceo-discusses-q2-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1511332",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-06-19T18:05:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Discusses Positive Data from Human Abuse Liability Study for NKTR-181 (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1511332-nektar-therapeutics-ceo-discusses-positive-data-from-human-abuse-liability-study-for-nktrminus-181-transcript"
        }
    },
    {
        "id": "1450081",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-21T12:00:02-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Presents at UBS Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1450081-nektar-therapeutics-ceo-presents-at-ubs-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1422771",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-05-10T00:20:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar's CEO Discusses Q1 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1422771-nektars-ceo-discusses-q1-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1236801",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-02-28T22:55:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics CEO Discusses Q4 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1236801-nektar-therapeutics-ceo-discusses-q4-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "1103031",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-01-09T13:43:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Presents at JP Morgan Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1103031-nektar-therapeutics-ceo-presents-at-jp-morgan-healthcare-conference-transcript"
        }
    },
    {
        "id": "1000491",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-11-12T13:28:00-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Discusses Naloxegol Study Results Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1000491-nektar-therapeutics-ceo-discusses-naloxegol-study-results-conference-transcript"
        }
    },
    {
        "id": "876911",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-09-19T16:34:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Presents at UBS Global Life Sciences Conference - Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/876911-nektar-therapeutics-ceo-presents-at-ubs-global-life-sciences-conference-transcript"
        }
    },
    {
        "id": "796681",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-08-09T23:09:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics' CEO Discusses Q2 2012 Results - Earnings Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/796681-nektar-therapeutics-ceo-discusses-q2-2012-results-earnings-transcript"
        }
    },
    {
        "id": "234924",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-11-04T23:00:44-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar CEO Discusses Q3 2010 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/234924-nektar-ceo-discusses-q3-2010-results-earnings-call-transcript"
        }
    },
    {
        "id": "217188",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-07-29T03:08:13-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q2 2010 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/217188-nektar-therapeutics-q2-2010-earnings-call-transcript"
        }
    },
    {
        "id": "203262",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-05-06T00:03:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q1 2010 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/203262-nektar-therapeutics-q1-2010-earnings-call-transcript"
        }
    },
    {
        "id": "153783",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-08-04T22:57:17-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q2 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/153783-nektar-therapeutics-q2-2009-earnings-call-transcript"
        }
    },
    {
        "id": "123681",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-03-02T20:29:13-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics F4Q08 and Year End 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/123681-nektar-therapeutics-f4q08-and-year-end-2008-earnings-call-transcript"
        }
    },
    {
        "id": "123652",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-03-02T18:58:10-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics, Q4 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/123652-nektar-therapeutics-q4-2008-earnings-call-transcript"
        }
    },
    {
        "id": "106948",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-11-20T04:37:10-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q3 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/106948-nektar-therapeutics-q3-2008-earnings-call-transcript"
        }
    },
    {
        "id": "90114",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-08-09T15:33:15-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q2 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/90114-nektar-therapeutics-q2-2008-earnings-call-transcript"
        }
    },
    {
        "id": "77868",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-05-19T13:35:11-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q1 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/77868-nektar-therapeutics-q1-2008-earnings-call-transcript"
        }
    },
    {
        "id": "67891",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-03-10T13:07:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Nektar Therapeutics Q4 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1952",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/67891-nektar-therapeutics-q4-2007-earnings-call-transcript"
        }
    }
]